R&D Changing Faces: Pharma and biotech, March 2026 A broad mix of senior leadership and scientific and commercial appointments shaped last month’s pharma and biotech hiring activity.
R&D Changing Faces: Pharma and biotech, February 2026 The pharmaceutical and biotech sectors have seen a flurry of executive movement this month.
R&D Changing Faces: Pharma and biotech, January 2026 The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms.
R&D Changing Faces: Pharma and biotech hires, November and Decem... In our final batch of Changing Faces columns from 2025, we’re detailing a flurry of senior leadership appointments in recent months.
R&D Changing Faces - Pharma and biotech - October 2025 From high-profile resignations to strategic appointments, October was a buzzy month for pharma industry personnel news.
Sales & Marketing Changing Faces – Pharma and biotech hires – August and Septe... It’s been a busy couple of months in the world of pharma hires as Merck KGaA and GSK both made some big changes at the top.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
